Hepcidin in human iron disorders: Therapeutic implications

This publication has 91 references indexed in Scilit:

• BMP6 Treatment Compensates for the Molecular Defect and Ameliorates Hemochromatosis in Hfe Knockout Mice
  Gastroenterology, 2010
• Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
  American Journal of Kidney Diseases, 2010
• BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
  Nature Genetics, 2009
• The Serine Protease Matriptase-2 (TMPRSS6) Inhibits Hepcidin Activation by Cleaving Membrane Hemojuvelin
  Cell Metabolism, 2008
• Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
  Nature Genetics, 2008
• Neogenin Interacts with Hemojuvelin through Its Two Membrane-Proximal Fibronectin Type III Domains
  Biochemistry, 2008
• The Transferrin Receptor Modulates Hfe-Dependent Regulation of Hepcidin Expression
  Cell Metabolism, 2008
• Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin
  Blood Cells, Molecules, and Diseases, 2008
• Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism
  Nature Chemical Biology, 2007
• Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
  Nature Genetics, 2002